InsidersTradesSigma
PHARMANUTRA RISULTATI PRIMO SEMESTRE 2023: management transactions · Italy · Consob
CONSOB:pharmanutra-risultati-primo-semestre-2023IT·ConsobMcap 862M€Healthcare
Browse the full directors' dealings record of PHARMANUTRA RISULTATI PRIMO SEMESTRE 2023, a listed issuer based in Italy. Shares are listed on IT IT, under the oversight of Consob. Operating in the Healthcare sector, PHARMANUTRA RISULTATI PRIMO SEMESTRE 2023 has logged 1 reports. Market capitalisation: €861.8m. The latest transaction was filed on 11 September 2023 — Other. Among the most active insiders: Unknown. Every trade is free.
1
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
90.00 €
Analyst consensus
3 analystsStrong buy
76.00 €Target 81.33 €(-10%)86.00 €
Income statement
Revenue132.9 M€
Gross profit102.9 M€77% margin
Net income20.0 M€15.2% margin
Valuation
PER (trailing)40.9x
PER (forward)29.4x
P/Book12.1x
Balance sheet & cash
Market cap861.8 M€
Total debt20.5 M€
Free Cash Flow16.4 M€
Debt / Equity26%
Profitability & ownership
ROE30.1%
ROA15.1%
% insiders65.0%
% institutions16.1%
Last declaration on 11 September 2023
Declarations1 total
Executives●Other0Consob
CONSOB:136631·details not loaded
1 of 1 declaration